Browsing by Author "Selmaj, Krzysztof W."
Now showing items 1-2 of 2
-
Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Up to 5 years of follow-up in the DAYBREAK open-label extension trial
Cree, Bruce; Selmaj, Krzysztof W.; Steinman, Lawrence; Comi, Giancarlo; Bar-Or, Amit; Arnold, Douglas L; Montalban Gairín, Xavier (SAGE Publications, 2022-10) -
Ozanimod in relapsing multiple sclerosis: Pooled safety results from the clinical development program
Selmaj, Krzysztof W.; Cohen, Jeffrey A; Comi, Giancarlo; Bar-Or, Amit; Arnold, Douglas L; Steinman, Lawrence; Montalban Gairín, Xavier (Elsevier, 2021-06)